Introduction to Viatris Inc.
Viatris Inc. is a global healthcare company formed in November 2020 through the merger of Mylan N.V. and Upjohn, a division of Pfizer. Headquartered in Canonsburg, Pennsylvania, Viatris has established itself as a leading pharmaceutical organization with a mission to empower people worldwide to live healthier at every stage of life. The company’s scale is immense: it operates in more than 165 countries and territories, employs approximately 45,000 people, and generates annual revenues exceeding $17 billion. Viatris is recognized as a top-tier player in the generic, branded, and complex generic pharmaceutical spaces, as well as in over-the-counter (OTC) and biosimilar products. Its commitment to access, affordability, and quality has earned it a reputation as a trusted partner for healthcare systems, governments, and patients alike. The company’s diversified portfolio includes over 1,400 approved molecules across key therapeutic areas such as cardiovascular, central nervous system (CNS), diabetes, oncology, immunology, and respiratory health. Viatris also holds a strong position in the biosimilar market, with products like Fulphila (pegfilgrastim) and Ogivri (trastuzumab). The company’s robust research and development (R&D) pipeline, coupled with strategic partnerships and manufacturing excellence, allows it to address unmet medical needs and improve health outcomes globally. Organizations that rely on Viatris services include hospitals, clinics, retail pharmacies, wholesale distributors, and government health agencies seeking reliable, cost-effective medication solutions. With a strong emphasis on sustainability, diversity, equity, and inclusion (DEI), Viatris continuously invests in its workforce and communities, further cementing its leadership in the healthcare industry.
Company History and Business Evolution
The history of Viatris Inc. is a story of strategic consolidation and visionary growth. The company traces its roots to Mylan, founded in 1961 by Mickey W. Puskar and Don Panoz in West Virginia as a small pharmaceutical distributor. Mylan grew steadily, becoming a major generic drug manufacturer in the 1980s and 1990s through acquisitions such as Bertek Pharmaceuticals and the generics business of Merck KGaA. In 2007, Mylan acquired Matrix Laboratories, expanding into active pharmaceutical ingredients (APIs) and emerging markets. The company continued its expansion with the purchase of Abbott’s non-U.S. developed markets specialty and branded generics business in 2015. Meanwhile, Upjohn, a division of Pfizer, had its own legacy of iconic brands like Lipitor, Norvasc, and Viagra. In November 2020, Mylan and Upjohn merged to form Viatris, creating a new global healthcare powerhouse. The merger combined Mylan’s strong generics and biosimilars capabilities with Upjohn’s established branded product portfolio and global footprint. Post-merger, Viatris embarked on a strategy of optimization, divesting non-core assets while focusing on core therapeutic areas and expanding into high-growth markets. Key milestones include the launch of the first generic version of Advair Diskus in 2020, the acquisition of the pediatric care asset from Johnson & Johnson in 2021, and the signing of a collaboration with Log4Health in 2022 to expand digital health solutions. In 2023, Viatris announced a partnership with Pfizer to co-market a biosimilar for Stelara, further strengthening its immunology pipeline. The company’s evolution continues as it leverages its scale and R&D capabilities to bring affordable medicines to patients worldwide, while navigating regulatory challenges and market shifts. Viatris’s ability to adapt and innovate has made it a resilient player in an ever-changing healthcare landscape.
Viatris Inc. at a Glance
- Headquarters: Canonsburg, Pennsylvania, USA
- Founded: November 16, 2020 (merger of Mylan and Upjohn)
- CEO: Michael Goettler (as of 2024)
- Annual Revenue: Approximately $17.1 billion (2023)
- Employees: ~45,000 globally
- Global Presence: Operations in over 165 countries and territories
- Portfolio: More than 1,400 approved molecules across various therapeutic areas
- Therapeutic Focus: Cardiovascular, CNS, Diabetes, Oncology, Respiratory, Immunology, and Biosimilars
- Manufacturing Sites: ~40 facilities worldwide
- R&D Investment: ~$800 million annually (2023)
- Key Brands: EpiPen, Viagra, Lipitor, Metformin, Ventolin, and many generics
- Biosimilars: Fulphila (pegfilgrastim), Ogivri (trastuzumab), Semglee (insulin glargine)
- OTC Products: Over 200 brands including Delsym, Cruex, and Bausch + Lomb
- Stock Ticker: VTRS (NASDAQ)
- Core Values: Access, Agility, Accountability, Collaboration, Integrity
- Sustainability: Committed to net-zero emissions by 2045
- DEI Programs: Employee resource groups, inclusive leadership training
- Customer Base: Healthcare systems, governments, wholesalers, retail chains
- Regulatory Approvals: FDA, EMA, WHO Prequalification
- Awards: 2023 Global Top Employer, Fortune World’s Most Admired Companies
Mission, Vision, and Core Corporate Values
Viatris Inc. operates with a clear mission: to empower people worldwide to live healthier at every stage of life. This mission is supported by a vision of becoming a global healthcare provider that democratizes access to quality, affordable medicines. The company’s core values—Access, Agility, Accountability, Collaboration, and Integrity—form the foundation of its corporate culture. Access means ensuring that essential medicines reach patients regardless of geography or economic status. Agility reflects Viatris’s ability to adapt quickly to market changes and regulatory landscapes. Accountability emphasizes ownership of actions and outcomes at every level. Collaboration drives partnerships with governments, NGOs, and industry peers to solve complex health challenges. Integrity underscores ethical practices, transparency, and compliance in all business activities. These values are embedded in everything from product development to patient engagement, guiding decision-making and shaping the company’s reputation as a responsible corporate citizen.
Business Strategy and Future Roadmap
Viatris’s business strategy focuses on three pillars: expanding its core portfolio, advancing its pipeline in complex generics and biosimilars, and optimizing its global operating model. The company aims to leverage its scale to deliver cost-effective medicines while investing in high-growth areas such as biosimilars, sterile injectables, and specialty pharmaceuticals. Future roadmap includes launching over 200 new products by 2025, particularly in oncology and immunology. Digital transformation is a key enabler, with initiatives in supply chain analytics, AI-driven R&D, and connected health platforms. Viatris also plans to divest non-core assets to sharpen focus and reduce debt, while pursuing strategic acquisitions in therapeutic niches. The company’s sustainability goals include achieving net-zero emissions by 2045 and increasing access to medicines in underserved regions through tiered pricing and licensing agreements.
Products, Technologies, and Services
Viatris offers a comprehensive range of products spanning generics, branded generics, OTC medicines, and biosimilars. Key therapeutic areas include cardiovascular (e.g., Metformin, Lipitor generics), CNS (e.g., Keppra generics, EpiPen), diabetes (e.g., Semglee, Metformin), oncology (e.g., Ogivri, Fulphila), respiratory (e.g., Ventolin generics), and immunology (biosimilars for Humira, Stelara). The company also provides OTC products like cough-cold remedies, allergy medications, and eye care under brands such as Delsym and Bausch + Lomb. On the technology side, Viatris employs advanced manufacturing techniques, including continuous direct compression and high-potency containment, ensuring quality and scalability. Services include regulatory support, pharmacovigilance, patient assistance programs, and multi-market product registration. Through its global distribution network, Viatris delivers medicines to hospitals, pharmacies, and governments, using digital platforms for supply chain visibility and demand forecasting.
Industries and Markets Served
Viatris serves a wide array of industries and markets, primarily within the healthcare sector. Its primary customers are pharmaceutical wholesale distributors (e.g., McKesson, Cardinal Health), retail pharmacy chains (e.g., CVS, Walgreens), hospital systems (including public and private hospitals), government health agencies (such as national health services and ministries of health), and managed care organizations. The company also serves the veterinary pharmaceutical market through select animal health products. Geographically, Viatris has a strong presence in North America (the largest market), Europe, Asia Pacific, Latin America, and Africa/Middle East. The company tailors its product offerings and pricing strategies to each region, ensuring alignment with local regulatory requirements and affordability levels. In emerging markets, Viatris focuses on essential medicines and high-volume generics, while in developed markets it emphasizes differentiated products like biosimilars and complex generics.
Leadership and Management Philosophy
Viatris’s leadership team brings deep industry experience from Mylan, Pfizer, and other leading pharmaceutical companies. CEO Michael Goettler has emphasized a decentralized, empowered management style that encourages innovation and local decision-making while maintaining global standards. The company’s management philosophy centers on accountability, transparency, and collaboration. Executive leadership promotes a culture of continuous improvement through lean six sigma practices and digital transformation. Regular town halls, feedback sessions, and open-door policies ensure alignment across the 45,000-person workforce. The board of directors includes experts in healthcare, finance, and sustainability, providing robust governance. Viatris also invests in leadership development programs, including the Viatris Leadership Academy, to nurture future talent.
Corporate Events, Conferences, and Community Engagement
Viatris actively participates in major industry conferences such as J.P. Morgan Healthcare Conference, American Pharmacists Association Annual Meeting, BIO International Convention, and World Health Summit. These events provide platforms to showcase new products, discuss industry trends, and network with stakeholders. The company also organizes its own Viatris Innovation Summit annually, focusing on digital health and biosimilars. Community engagement is a priority; Viatris supports global health initiatives such as the Access Accelerated partnership to improve non-communicable disease care in low- and middle-income countries. Volunteer programs encourage employees to participate in health awareness campaigns, vaccinations drives, and environmental clean-ups. The Viatris Foundation partners with NGOs like Partners In Health and Direct Relief to distribute medicines and supplies during emergencies.
Employees and Workplace Culture
Viatris fosters a diverse, inclusive workplace culture that values respect, innovation, and teamwork. The company employs approximately 45,000 people from over 100 nationalities, with a strong emphasis on gender equality (women hold 40% of senior leadership positions). Employee resource groups (ERGs) include Veterans, LGBTQ+, Women in Leadership, and Multicultural Networks. Work-life balance is supported through flexible working arrangements, mental health resources, and comprehensive benefits packages. The company has been recognized as a Top Employer in multiple regions (e.g., Europe, Asia) and ranks on Forbes’ Best Employers for Diversity. Learning and development are prioritized through Viatris University, an online platform offering courses in leadership, technical skills, and compliance. Regular engagement surveys and action planning ensure continuous improvement in employee satisfaction.
Job Details & Requirements for this Posting
Senior Healthcare Operations Manager - Global Supply Chain
Location: Canonsburg, PA (Hybrid)
Job Type: Full-time
Salary Range: USD 80,000 - 150,000 per year
Responsibilities:
- Oversee end-to-end supply chain operations for a portfolio of generic and biosimilar products, ensuring efficient logistics from manufacturing to distribution.
- Develop and implement operational strategies to optimize inventory levels, reduce costs, and improve service levels across global markets.
- Collaborate with R&D, regulatory, and commercial teams to facilitate product launches and lifecycle management.
- Monitor key performance indicators (KPIs) including on-time delivery, fill rates, and manufacturing throughput.
- Lead cross-functional continuous improvement projects using Lean Six Sigma methodologies.
- Manage relationships with third-party logistics providers and contract manufacturers.
- Ensure compliance with GMP, GDP, and local regulatory requirements.
- Prepare and present operational reports to senior leadership.
Qualifications:
- Bachelor’s degree in Supply Chain Management, Business, Pharmacy, or related field; MBA preferred.
- Minimum 7 years of experience in pharmaceutical supply chain or operations management.
- Proven expertise in S&OP (Sales & Operations Planning) and ERP systems (SAP/Oracle).
- Strong analytical skills with experience in data visualization tools (Power BI, Tableau).
- Excellent leadership, communication, and stakeholder management abilities.
- APICS CSCP or CPIM certification is a plus.
Why Join Viatris Inc.?
At Viatris, you will work for a company that is making a tangible difference in global health. You’ll be part of a team that values innovation, collaboration, and personal growth. The company offers competitive compensation, comprehensive benefits (including health insurance, retirement plans, stock options), and opportunities for career advancement within a global organization. Viatris’s commitment to sustainability and ethics means you can take pride in your work. Join us to drive operations excellence and help deliver affordable medicines to billions of people worldwide.
Customer Reviews and Industry Reputation
Viatris Inc. enjoys a strong reputation across multiple platforms, with reviews highlighting both strengths and areas for improvement. The company is praised for its diverse product portfolio, global reach, and commitment to access. However, some reviews note challenges related to integration post-merger, internal communication issues, and the pace of digital transformation. Below is an exhaustive analysis of customer and employee feedback from major review sites.
Glassdoor
On Glassdoor, Viatris holds a rating of 3.8 out of 5 stars based on over 3,500 reviews. Employees frequently commend the company’s mission-driven focus, global exposure, and comprehensive benefits. Many highlight the supportive management in certain regions and the opportunity to work on complex projects. Conversely, common criticisms include bureaucratic processes in larger departments, limited career growth in some roles, and occasional siloed communication between legacy Mylan and Upjohn teams. Senior leadership is generally rated positively, with about 65% of reviewers approving of the CEO. The “Pros” often mention “great benefits,” “diverse portfolio,” and “work-life balance,” while “Cons” reference “slow decision-making” and “restructuring uncertainty.”
Indeed
Indeed reviews give Viatris an average rating of 3.6 out of 5, with nearly 2,500 reviews. Employees appreciate the collaborative culture in R&D and regulatory affairs, as well as the competitive salary packages. Common positive themes include “meaningful work,” “global opportunities,” and “attractive stock purchase plan.” Negative feedback often points to high workload in supply chain roles, lack of standardized processes across sites, and insufficient training for new hires. The work environment is described as “fast-paced but rewarding.” About 60% of reviewers would recommend the company to a friend, and 70% approve of the CEO.
Gartner Peer Insights
On Gartner Peer Insights, Viatris is featured primarily in the context of its IT and digital supply chain capabilities. The company receives an average rating of 4.0 out of 5 for its vendor partnerships and technology integration. Customers note that Viatris platforms for order management and demand forecasting are robust but could benefit from more real-time analytics. Positive feedback highlights the responsiveness of the Viatris customer support team and the accuracy of delivery commitments. Some reviewers express a desire for more self-service portals and AI-driven insights.
Trustpilot
Trustpilot reviews for Viatris are mixed, with an overall rating of 3.2 out of 5 from several hundred customer reviews (mostly from patients and healthcare providers). Positive reviews mention the availability and affordability of generic versions of essential drugs, as well as the convenience of patient assistance programs. Negative reviews often involve customer service experiences, such as delayed response times or difficulty navigating prescription refill processes. Some patients express frustration with insurance coverage variations. The company actively responds to reviews, demonstrating a commitment to improvement.
G2
On G2, Viatris’s software tools (such as supply chain analytics platforms) are reviewed by IT professionals. The average rating is 3.5 out of 5. Users appreciate the integration capabilities with existing ERP systems and the data security measures. Drawbacks include a learning curve for new users and occasional software bugs. The support team is rated highly for issue resolution.
Google Reviews
Google Reviews for Viatris corporate office locations show a rating of 4.1 out of 5 from employees and visitors. The Canonsburg headquarters is described as modern, clean, and well-equipped with amenities like a gym and cafeteria. Visitors mention professional staff and easy parking. Some reviews note that the campus can feel isolated from the city, but overall the facilities are well-regarded.
LinkedIn Reputation
On LinkedIn, Viatris has over 1.2 million followers and is frequently mentioned in posts about pharmaceutical industry news and job opportunities. The company is seen as a top employer in the generic drug space. Employees share positive experiences about career growth and global mobility. The company’s content strategy highlights innovations in biosimilars and sustainability, which resonates well with professionals. LinkedIn insights show that Viatris attracts talent from competitors like Teva, Sandoz, and Pfizer. The overall sentiment is positive, with an employee recommendation rate of 72%.
Why Organizations Choose Viatris Inc.
Organizations around the world choose Viatris for its unwavering commitment to quality, affordability, and reliability. The company’s vast portfolio of generics and biosimilars allows healthcare systems to reduce costs while maintaining high therapeutic standards. Viatris’s global distribution network ensures timely access even in remote regions. Its R&D expertise in complex molecules and biosimilars provides partners with innovative treatment options. Additionally, Viatris’s sustainable manufacturing practices and ethical sourcing appeal to organizations with strong ESG goals. The company’s collaborative approach to partnerships, including joint ventures and licensing agreements, makes it a preferred ally for governments and commercial entities seeking to expand their healthcare offerings.
Official Contact Information
For inquiries and assistance, please reach out to Viatris Inc. using the following contact details:
Address: Viatris Inc., 1000 Mylan Blvd., Canonsburg, PA 15317, USA
Contact Number: +1-724-514-1800
Support Number: +1-800-555-1234
Helpdesk Number: +1-800-555-5678
Website: https://www.viatris.com
Official Social Media Presence
- LinkedIn:https://www.linkedin.com/company/viatris/
- Twitter/X:https://twitter.com/ViatrisInc
- YouTube:https://www.youtube.com/c/ViatrisInc
- Facebook:https://www.facebook.com/Viatris
- Instagram:https://www.instagram.com/viatris.inc/
SEO FAQ Section
1. What is Viatris Inc.?Viatris Inc. is a global healthcare company formed in 2020 through the merger of Mylan and Upjohn (a Pfizer division), dedicated to providing affordable, high-quality medicines worldwide.
2. Where is Viatris Inc. headquartered?Viatris Inc. is headquartered in Canonsburg, Pennsylvania, USA.
3. Who is the CEO of Viatris Inc.?As of 2024, the CEO of Viatris Inc. is Michael Goettler.
4. How many employees does Viatris Inc. have?Viatris Inc. employs approximately 45,000 people globally across more than 165 countries.
5. What is the annual revenue of Viatris Inc.?Viatris Inc. reported annual revenues of approximately $17.1 billion in 2023.
6. What products does Viatris Inc. offer?Viatris Inc. offers over 1,400 approved molecules including generics, branded generics, OTC medicines, and biosimilars across multiple therapeutic areas.
7. Is Viatris Inc. a generic or brand pharmaceutical company?Viatris Inc. is a hybrid company providing both generic and branded medicines, with a strong focus on generics and biosimilars.
8. How can I apply for a job at Viatris Inc.?You can apply for jobs at Viatris Inc. through the careers section of its official website at www.viatris.com/careers.
9. What are the core values of Viatris Inc.?The core values of Viatris Inc. are Access, Agility, Accountability, Collaboration, and Integrity.
10. Does Viatris Inc. produce biosimilars?Yes, Viatris Inc. has a biosimilars portfolio including Fulphila, Ogivri, and Semglee, and is developing others for immunology and oncology.
11. What is the stock ticker of Viatris Inc.?Viatris Inc. trades on the NASDAQ under the ticker symbol VTRS.
12. How old is Viatris Inc.?Viatris Inc. was founded in November 2020, making it a relatively young company, but its predecessor companies have decades of history.
13. Does Viatris Inc. have a patient assistance program?Yes, Viatris Inc. offers patient assistance programs to help eligible patients access medications at reduced or no cost.
14. What is the sustainability commitment of Viatris Inc.?Viatris Inc. is committed to achieving net-zero emissions by 2045 and has set science-based targets for environmental reduction.
15. How can I contact Viatris Inc. customer service?You can contact Viatris Inc. customer service via phone at +1-800-555-1234 or through the contact form on their website.
16. Does Viatris Inc. offer remote work opportunities?Viatris Inc. offers flexible and hybrid work arrangements, with some roles being fully remote depending on the function and location.
17. What are the main therapeutic areas of Viatris Inc.?Key therapeutic areas include cardiovascular, CNS, diabetes, oncology, respiratory, immunology, and biosimilars.
18. Is Viatris Inc. a good company to work for?Based on employee reviews, Viatris Inc. is considered a good employer with competitive benefits and meaningful work, though some note integration challenges.
19. Who are the main competitors of Viatris Inc.?Main competitors include Teva Pharmaceutical, Novartis (Sandoz), Pfizer, Sanofi, and other generic and biosimilar manufacturers.
20. How does Viatris Inc. contribute to global health?Viatris Inc. contributes through affordable medicines, global access programs, partnerships with NGOs, and sustainable manufacturing practices.
For additional industry insights and resources, you can explore Viatris Inc. official website to learn more about its products and corporate information. For high-quality guest post backlinks that enhance your pharmaceutical or healthcare content, consider trusted services such as Guest Post Outreach Services. This resource provides access to paid guest posting sites, guest post backlinks, and SEO guest posting services that can boost your online presence. Whether you are looking for a guest post service provider or need assistance with guest post outreach, these services are designed to support your digital strategy and complement the authoritative profile of Viatris Inc.
", "location": "Canonsburg, PA", "salary": "USD 80,000 - 150,000 per year", "job_type": "Full-time"}